Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OLO
3526
DELISTED
Olo Inc
OLO
| $168K | ﹤0.01% |
38,121
-62,730
| -62% | -$297K |
|
3527
CB Financial Services
CBFV
$193M
| $168K | ﹤0.01% |
7,430
| – | – |
|
3528
TPG
TPG
$7.86B
| $168K | ﹤0.01% |
4,057
-13,311
| -77% | -$569K |
|
3529
MetroCity Bankshares
MCBS
$1.03B
| $168K | ﹤0.01% |
6,362
-9,884
| -61% | -$241K |
|
3530
Mesa Laboratories
MLAB
$574M
| $168K | ﹤0.01% |
1,932
-2,762
| -59% | -$289K |
|
3531
MediaAlpha
MAX
$821M
| $167K | ﹤0.01% |
12,716
-8,199
| -39% | -$151K |
|
3532
SmartRent
SMRT
$272M
| $167K | ﹤0.01% |
70,019
-96,020
| -58% | -$236K |
|
|
PLL
3533
DELISTED
Piedmont Lithium
PLL
| $167K | ﹤0.01% |
16,753
-9,100
| -35% | -$116K |
|
3534
Carriage Services
CSV
$569M
| $167K | ﹤0.01% |
6,218
-7,501
| -55% | -$197K |
|
|
WOW
3535
DELISTED
WideOpenWest
WOW
| $166K | ﹤0.01% |
30,772
-17,891
| -37% | -$79.3K |
|
3536
Criteo S.A. Ordinary Shares
CRTO
$923M
| $166K | ﹤0.01% |
4,399
-1,116
| -20% | -$40.9K |
|
3537
Chemung Financial Corp
CHMG
$392M
| $166K | ﹤0.01% |
3,448
+396
| +13% | +$16.9K |
|
3538
Invesco Mortgage Capital
IVR
$805M
| $165K | ﹤0.01% |
17,654
-26,197
| -60% | -$236K |
|
3539
Perspective Therapeutics
CATX
$342M
| $165K | ﹤0.01% |
16,582
+9,681
| +140% | +$140K |
|
3540
CEVA Inc
CEVA
$1.08B
| $165K | ﹤0.01% |
8,554
-12,434
| -59% | -$252K |
|
3541
Sutro Biopharma
STRO
$421M
| $165K | ﹤0.01% |
5,626
-2,348
| -29% | -$92.8K |
|
3542
Fulcrum Therapeutics
FULC
$297M
| $165K | ﹤0.01% |
26,576
-44,939
| -63% | -$340K |
|
3543
Lightwave Logic
LWLG
$1.25B
| $165K | ﹤0.01% |
55,070
-49,270
| -47% | -$180K |
|
|
GRSD
3544
Grandstand Limited Ordinary Shares
GRSD
$67M
| $163K | ﹤0.01% |
19,838
-4,788
| -19% | -$40.4K |
|
|
TTSH
3545
DELISTED
Tile Shop Holdings
TTSH
| $162K | ﹤0.01% |
23,431
-10,110
| -30% | -$67.8K |
|
3546
Mission Produce
AVO
$1.17B
| $162K | ﹤0.01% |
16,412
-26,197
| -61% | -$300K |
|
3547
Farmers National Banc Corp
FMNB
$930M
| $162K | ﹤0.01% |
12,979
-19,697
| -60% | -$242K |
|
3548
Novartis
NVS
$297B
| $161K | ﹤0.01% |
1,513
+1,165
| +335% | +$117K |
|
|
EDR
3549
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $161K | ﹤0.01% |
5,950
-34,878
| -85% | -$927K |
|
|
DM
3550
DELISTED
Desktop Metal, Inc.
DM
| $161K | ﹤0.01% |
38,936
+18,333
| +89% | +$125K |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.